{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 8,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 1
      },
      "4": {
        "core": 1,
        "branch": 1
      },
      "5": {
        "core": 1,
        "branch": 0
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A10 → (¬G → A7))",
        "prover9_expression": "(adheres_to_protocol(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "Provided that patient1 adheres to the protocol, if the treatment in trial1 is not effective, then patient1 shows abstinence."
      },
      {
        "id": "Rule2",
        "formal": "(A12 → (A11 → A10))",
        "prover9_expression": "(investigator_blinded(researcher1) -> (attends_visits(patient1) -> adheres_to_protocol(patient1)))",
        "natural": "If researcher1 is blinded as an investigator, then whenever patient1 attends the study visits, patient1 adheres to the protocol."
      },
      {
        "id": "Rule3",
        "formal": "(A12 ∨ A13)",
        "prover9_expression": "(investigator_blinded(researcher1) | coordinator_blinded(nurse1))",
        "natural": "Either researcher1 is blinded as an investigator or nurse1 is blinded as a coordinator."
      },
      {
        "id": "Rule4",
        "formal": "(A13 → (A11 → A10))",
        "prover9_expression": "(coordinator_blinded(nurse1) -> (attends_visits(patient1) -> adheres_to_protocol(patient1)))",
        "natural": "If nurse1 is blinded as a coordinator, then given that patient1 attends the study visits, patient1 adheres to the protocol."
      },
      {
        "id": "Rule5",
        "formal": "(A15 ∨ (A14 ∨ G))",
        "prover9_expression": "(protocol_violation_occurs(trial1) | (data_audited(trial1) | treatment_effective(trial1)))",
        "natural": "A protocol violation occurs in trial1, or the data for trial1 is audited, or the treatment in trial1 is effective."
      },
      {
        "id": "Rule6",
        "formal": "(A16 → ¬A15)",
        "prover9_expression": "(monitoring_conducted(monitor1, trial1) -> -protocol_violation_occurs(trial1))",
        "natural": "Provided that monitor1 conducts monitoring for trial1, a protocol violation does not occur in trial1."
      },
      {
        "id": "Rule7",
        "formal": "(A16 ∨ A17)",
        "prover9_expression": "(monitoring_conducted(monitor1, trial1) | interim_analysis_done(statistician1, trial1))",
        "natural": "Monitor1 conducts monitoring for trial1, or statistician1 performs an interim analysis for trial1."
      },
      {
        "id": "Rule8",
        "formal": "(A19 → A20)",
        "prover9_expression": "(irb_approves(ethics_board, trial1) -> fda_approves(agency, trial1))",
        "natural": "If the ethics board (IRB) approves trial1, then the agency (FDA) approves trial1."
      },
      {
        "id": "Rule9",
        "formal": "(A19 → A43)",
        "prover9_expression": "(irb_approves(ethics_board, trial1) -> dsmb_reviews(committee1, trial1))",
        "natural": "If the ethics board (IRB) approves trial1, then committee1 (DSMB) reviews trial1."
      },
      {
        "id": "Rule10",
        "formal": "(A20 → (¬(A17 → ¬A15) → ¬A18))",
        "prover9_expression": "(fda_approves(agency, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
        "natural": "If the agency (FDA) approves trial1, then provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      {
        "id": "Rule11",
        "formal": "(A21 → G)",
        "prover9_expression": "(craving_reduced(patient1) -> treatment_effective(trial1))",
        "natural": "If craving is reduced for patient1, then the treatment in trial1 is effective."
      },
      {
        "id": "Rule12",
        "formal": "(A22 → G)",
        "prover9_expression": "(consumption_decreased(patient1) -> treatment_effective(trial1))",
        "natural": "Provided that consumption is decreased for patient1, the treatment in trial1 is effective."
      },
      {
        "id": "Rule13",
        "formal": "(A23 → A21)",
        "prover9_expression": "(receives_intervention(patient1) -> craving_reduced(patient1))",
        "natural": "If patient1 receives an intervention, then craving is reduced for patient1."
      },
      {
        "id": "Rule14",
        "formal": "(A24 → A22)",
        "prover9_expression": "(gets_support(patient1) -> consumption_decreased(patient1))",
        "natural": "Under the condition that patient1 gets support, consumption is decreased for patient1."
      },
      {
        "id": "Rule15",
        "formal": "(A26 → (A23 ∨ A24))",
        "prover9_expression": "(secondary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))",
        "natural": "If patient1 meets the secondary endpoint, then patient1 receives an intervention or gets support."
      },
      {
        "id": "Rule16",
        "formal": "(A28 → (A27 → (A25 → A26)))",
        "prover9_expression": "(paper_published(trial1, journal1) -> (statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))))",
        "natural": "If a paper for trial1 is published in journal1, then given that statistical significance is reached, if patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
      },
      {
        "id": "Rule17",
        "formal": "(A28 ∨ A29)",
        "prover9_expression": "(paper_published(trial1, journal1) | results_presented(trial1, conference1))",
        "natural": "A paper for trial1 is published in journal1, or the results of trial1 are presented at conference1."
      },
      {
        "id": "Rule18",
        "formal": "(A29 → (A27 → (A25 → A26)))",
        "prover9_expression": "(results_presented(trial1, conference1) -> (statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))))",
        "natural": "If the results of trial1 are presented at conference1, then under the condition that statistical significance is reached, if patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
      },
      {
        "id": "Rule19",
        "formal": "(A30 → G)",
        "prover9_expression": "(biological_sample_collected(patient1, blood) -> treatment_effective(trial1))",
        "natural": "Provided that a biological sample (blood) is collected from patient1, the treatment in trial1 is effective."
      },
      {
        "id": "Rule20",
        "formal": "(A36 → (¬(A34 → A33) → A35))",
        "prover9_expression": "(ema_reviews(agency_eu, trial1) -> (-(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1)) -> dose_adjusted(patient1)))",
        "natural": "Whenever the European agency (EMA) reviews trial1, then if it is not the case that 'if patient1 has a poor metabolizer status, then a pharmacogenetic response occurs', the dose for patient1 is adjusted."
      },
      {
        "id": "Rule21",
        "formal": "(A37 → (¬G → A7))",
        "prover9_expression": "(uses_diary(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "If patient1 uses a diary, then if the treatment in trial1 is not effective, patient1 shows abstinence."
      },
      {
        "id": "Rule22",
        "formal": "(A37 ∨ A38)",
        "prover9_expression": "(uses_diary(patient1) | wears_sensor(patient1))",
        "natural": "Patient1 uses a diary, or patient1 wears a sensor."
      },
      {
        "id": "Rule23",
        "formal": "(A4 → (A3 → ¬A2))",
        "prover9_expression": "(receives_placebo(patient1) -> (reports_adverse_event(patient1, headache) -> -experiences_side_effect(patient1, nausea)))",
        "natural": "If patient1 receives a placebo, then whenever patient1 reports a headache as an adverse event, patient1 does not experience nausea as a side effect."
      },
      {
        "id": "Rule24",
        "formal": "(A40 → ¬A39)",
        "prover9_expression": "(questionnaire_completed(patient1, audit_c) -> -data_missing(patient1))",
        "natural": "If patient1 completes the AUDIT-C questionnaire, then data is not missing for patient1."
      },
      {
        "id": "Rule25",
        "formal": "(A41 → ¬A39)",
        "prover9_expression": "(interview_conducted(clinician1, patient1) -> -data_missing(patient1))",
        "natural": "Under the condition that clinician1 conducts an interview with patient1, data is not missing for patient1."
      },
      {
        "id": "Rule26",
        "formal": "(A42 ∨ (A40 ∨ A41))",
        "prover9_expression": "(funding_continued(grant1) | (questionnaire_completed(patient1, audit_c) | interview_conducted(clinician1, patient1)))",
        "natural": "Grant1 funding is continued, or patient1 completes the AUDIT-C questionnaire, or clinician1 conducts an interview with patient1."
      },
      {
        "id": "Rule27",
        "formal": "(A44 → (A43 → (¬(A17 → ¬A15) → ¬A18)))",
        "prover9_expression": "(protocol_amended(trial1, version2) -> (dsmb_reviews(committee1, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1))))",
        "natural": "If the protocol for trial1 is amended to version2, then given that committee1 (DSMB) reviews trial1, if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      {
        "id": "Rule28",
        "formal": "(A46 ∨ (¬A44 → A45))",
        "prover9_expression": "(multicenter_expansion(trial1) | (-protocol_amended(trial1, version2) -> recruitment_paused(trial1)))",
        "natural": "Trial1 undergoes a multicenter expansion, or if the protocol for trial1 is not amended to version2, then recruitment for trial1 is paused."
      },
      {
        "id": "Rule29",
        "formal": "(A47 ∨ A48)",
        "prover9_expression": "(follow_up_completed(patient1, month6) | long_term_data_collected(patient1, year1))",
        "natural": "Patient1 completes the 6-month follow-up, or long-term data is collected from patient1 at year1."
      },
      {
        "id": "Rule30",
        "formal": "(A48 → (A25 → (A23 ∨ A24)))",
        "prover9_expression": "(long_term_data_collected(patient1, year1) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1))))",
        "natural": "If long-term data is collected from patient1 at year1, then whenever patient1 meets the primary endpoint, patient1 receives an intervention or gets support."
      },
      {
        "id": "Rule31",
        "formal": "(A49 ∨ (A47 → (A25 → (A23 ∨ A24))))",
        "prover9_expression": "(replication_study_initiated(trial2) | (follow_up_completed(patient1, month6) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))))",
        "natural": "Replication study trial2 is initiated, or if patient1 completes the 6-month follow-up, then given that patient1 meets the primary endpoint, patient1 receives an intervention or gets support."
      },
      {
        "id": "Rule32",
        "formal": "(A6 ∨ (A5 → A4))",
        "prover9_expression": "(has_contraindication(patient1, liver_condition) | (is_randomized(patient1, groupA) -> receives_placebo(patient1)))",
        "natural": "Patient1 has a contraindication (a liver condition), or if patient1 is randomized into groupA, then patient1 receives a placebo."
      },
      {
        "id": "Rule33",
        "formal": "(A8 → A11)",
        "prover9_expression": "(takes_study_drug(patient1, naltrexone) -> attends_visits(patient1))",
        "natural": "If patient1 takes the study drug, naltrexone, then patient1 attends the study visits."
      },
      {
        "id": "Rule34",
        "formal": "(A8 ∨ A9)",
        "prover9_expression": "(takes_study_drug(patient1, naltrexone) | receives_counseling(patient1))",
        "natural": "Patient1 takes the study drug, naltrexone, or patient1 receives counseling."
      },
      {
        "id": "Rule35",
        "formal": "(A9 → (¬G → A7))",
        "prover9_expression": "(receives_counseling(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "Under the condition that patient1 receives counseling, if the treatment in trial1 is not effective, then patient1 shows abstinence."
      },
      {
        "id": "Rule36",
        "formal": "(¬(A1 → G) → A2)",
        "prover9_expression": "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> experiences_side_effect(patient1, nausea))",
        "natural": "If it is not the case that 'if patient1 completes trial1, then the treatment is effective', then patient1 experiences nausea as a side effect."
      },
      {
        "id": "Rule37",
        "formal": "(¬(A1 → G) → A3)",
        "prover9_expression": "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> reports_adverse_event(patient1, headache))",
        "natural": "Provided that it is not the case that 'if patient1 completes trial1, then the treatment is effective', patient1 reports a headache as an adverse event."
      },
      {
        "id": "Rule38",
        "formal": "(¬(A17 → ¬A15) → A18)",
        "prover9_expression": "(-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> trial_halted(trial1))",
        "natural": "Whenever it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is halted."
      },
      {
        "id": "Rule39",
        "formal": "(¬(A38 → (¬G → A7)) → A39)",
        "prover9_expression": "(-(wears_sensor(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1))) -> data_missing(patient1))",
        "natural": "Under the condition that it is not the case that 'if patient1 wears a sensor, then if the treatment is not effective, patient1 shows abstinence', data is missing for patient1."
      },
      {
        "id": "Rule40",
        "formal": "(¬(¬(¬A30 → A31) → A32) → A34)",
        "prover9_expression": "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> metabolizer_status(patient1, poor))",
        "natural": "Provided that it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', patient1 has a poor metabolizer status."
      },
      {
        "id": "Rule41",
        "formal": "(¬(¬(¬A30 → A31) → A32) → ¬A33)",
        "prover9_expression": "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> -pharmacogenetic_response(patient1))",
        "natural": "If it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', then a pharmacogenetic response does not occur in patient1."
      },
      {
        "id": "Rule42",
        "formal": "(¬A30 → ¬A31)",
        "prover9_expression": "(-biological_sample_collected(patient1, blood) -> -biomarker_analyzed(lab1, sample1))",
        "natural": "Provided that a biological sample is not collected from patient1, lab1 does not analyze biomarker sample1."
      },
      {
        "id": "Rule43",
        "formal": "(¬A44 → ¬A45)",
        "prover9_expression": "(-protocol_amended(trial1, version2) -> -recruitment_paused(trial1))",
        "natural": "Under the condition that the protocol for trial1 is not amended to version2, recruitment for trial1 is not paused."
      },
      {
        "id": "Rule44",
        "formal": "(¬G → ¬A7)",
        "prover9_expression": "(-treatment_effective(trial1) -> -shows_abstinence(patient1))",
        "natural": "Provided that the treatment in trial1 is not effective, patient1 does not show abstinence."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A1",
        "prover9_expression": "participant_completes(patient1, trial1)",
        "natural": "Patient1 completes trial1."
      },
      {
        "id": "Fact2",
        "formal": "A19",
        "prover9_expression": "irb_approves(ethics_board, trial1)",
        "natural": "The ethics board (IRB) approves trial1."
      },
      {
        "id": "Fact3",
        "formal": "A25",
        "prover9_expression": "primary_endpoint_met(patient1)",
        "natural": "Patient1 meets the primary endpoint."
      },
      {
        "id": "Fact4",
        "formal": "A27",
        "prover9_expression": "statistical_significance_reached(trial1, outcome1)",
        "natural": "Statistical significance for outcome1 is reached in trial1."
      },
      {
        "id": "Fact5",
        "formal": "A36",
        "prover9_expression": "ema_reviews(agency_eu, trial1)",
        "natural": "The European agency (EMA) reviews trial1."
      },
      {
        "id": "Fact6",
        "formal": "A5",
        "prover9_expression": "is_randomized(patient1, groupA)",
        "natural": "Patient1 is randomized into groupA."
      },
      {
        "id": "Fact7",
        "formal": "¬A14",
        "prover9_expression": "-data_audited(trial1)",
        "natural": "It is not the case that the data for trial1 is audited."
      },
      {
        "id": "Fact8",
        "formal": "¬A32",
        "prover9_expression": "-genetic_variant_found(patient1, allele1)",
        "natural": "A genetic variant (allele1) is not found in patient1."
      },
      {
        "id": "Fact9",
        "formal": "¬A35",
        "prover9_expression": "-dose_adjusted(patient1)",
        "natural": "The dose for patient1 is not adjusted."
      },
      {
        "id": "Fact10",
        "formal": "¬A42",
        "prover9_expression": "-funding_continued(grant1)",
        "natural": "Grant1 funding is not continued."
      },
      {
        "id": "Fact11",
        "formal": "¬A46",
        "prover9_expression": "-multicenter_expansion(trial1)",
        "natural": "Trial1 does not undergo a multicenter expansion."
      },
      {
        "id": "Fact12",
        "formal": "¬A49",
        "prover9_expression": "-replication_study_initiated(trial2)",
        "natural": "Replication study trial2 is not initiated."
      },
      {
        "id": "Fact13",
        "formal": "¬A6",
        "prover9_expression": "-has_contraindication(patient1, liver_condition)",
        "natural": "Patient1 does not have a contraindication: a liver condition."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "treatment_effective(trial1)",
    "natural": "The treatment in trial1 is effective."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | (A5 -> A4))",
            "-A6"
          ],
          "conclusion": "(A5 -> A4)",
          "natural": "If patient1 is randomized into groupA, then patient1 receives a placebo."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A5 -> A4)",
            "A5"
          ],
          "conclusion": "A4",
          "natural": "Patient1 receives a placebo."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A4 -> (A3 -> -A2))",
            "A4"
          ],
          "conclusion": "(A3 -> -A2)",
          "natural": "If patient1 reports a headache as an adverse event, then patient1 does not experience nausea as a side effect."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A1 -> G) -> A3)",
            "(A3 -> -A2)"
          ],
          "conclusion": "(-(A1 -> G) -> -A2)",
          "natural": "If it is not the case that 'if patient1 completes trial1, then the treatment is effective', then patient1 does not experience nausea as a side effect."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A1 -> G) -> A2)",
            "(-(A1 -> G) -> -A2)"
          ],
          "conclusion": "(A1 -> G)",
          "natural": "If patient1 completes trial1, then the treatment in trial1 is effective."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A1 -> G)",
            "A1"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A12 | A13)",
            "(A12 -> (A11 -> A10))",
            "(A13 -> (A11 -> A10))"
          ],
          "conclusion": "(A11 -> A10)",
          "natural": "Under the condition that patient1 attends the study visits, patient1 adheres to the protocol."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A11)",
            "(A11 -> A10)"
          ],
          "conclusion": "(A8 -> A10)",
          "natural": "If patient1 takes the study drug, naltrexone, then patient1 adheres to the protocol."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A10)",
            "(A10 -> (-G -> A7))"
          ],
          "conclusion": "(A8 -> (-G -> A7))",
          "natural": "Provided that patient1 takes the study drug, naltrexone, if the treatment in trial1 is not effective, then patient1 shows abstinence."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A8 | A9)",
            "(A8 -> (-G -> A7))",
            "(A9 -> (-G -> A7))"
          ],
          "conclusion": "(-G -> A7)",
          "natural": "If the treatment in trial1 is not effective, then patient1 shows abstinence."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A7)",
            "(-G -> -A7)"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A19 -> A20)",
            "(A20 -> (-(A17 -> -A15) -> -A18))"
          ],
          "conclusion": "(A19 -> (-(A17 -> -A15) -> -A18))",
          "natural": "Whenever the ethics board (IRB) approves trial1, then if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A19 -> (-(A17 -> -A15) -> -A18))",
            "A19"
          ],
          "conclusion": "(-(A17 -> -A15) -> -A18)",
          "natural": "Provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A17 -> -A15) -> A18)",
            "(-(A17 -> -A15) -> -A18)"
          ],
          "conclusion": "(A17 -> -A15)",
          "natural": "If statistician1 performs an interim analysis for trial1, then a protocol violation does not occur in trial1."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A16 | A17)",
            "(A16 -> -A15)",
            "(A17 -> -A15)"
          ],
          "conclusion": "-A15",
          "natural": "A protocol violation does not occur in trial1."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A15 | (A14 | G))",
            "-A15"
          ],
          "conclusion": "(A14 | G)",
          "natural": "Either the data for trial1 is audited, or the treatment in trial1 is effective."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A14 | G)",
            "-A14"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A28 | A29)",
            "(A28 -> (A27 -> (A25 -> A26)))",
            "(A29 -> (A27 -> (A25 -> A26)))"
          ],
          "conclusion": "(A27 -> (A25 -> A26))",
          "natural": "Provided that statistical significance for outcome1 is reached in trial1, then if patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A27 -> (A25 -> A26))",
            "A27"
          ],
          "conclusion": "(A25 -> A26)",
          "natural": "Whenever patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A25 -> A26)",
            "(A26 -> (A23 | A24))"
          ],
          "conclusion": "(A25 -> (A23 | A24))",
          "natural": "If patient1 meets the primary endpoint, then patient1 receives an intervention or gets support."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A25 -> (A23 | A24))",
            "A25"
          ],
          "conclusion": "(A23 | A24)",
          "natural": "Patient1 receives an intervention, or patient1 gets support."
        },
        {
          "step_number": 5,
          "rule_applied": "CD",
          "premises_used": [
            "(A23 -> A21)",
            "(A24 -> A22)",
            "(A23 | A24)"
          ],
          "conclusion": "(A21 | A22)",
          "natural": "Craving is reduced for patient1, or consumption is decreased for patient1."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A21 | A22)",
            "(A21 -> G)",
            "(A22 -> G)"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A36 -> (-(A34 -> A33) -> A35))",
            "A36"
          ],
          "conclusion": "(-(A34 -> A33) -> A35)",
          "natural": "If it is not the case that 'if patient1 has a poor metabolizer status, then a pharmacogenetic response occurs', then the dose for patient1 is adjusted."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A34 -> A33) -> A35)",
            "-A35"
          ],
          "conclusion": "(A34 -> A33)",
          "natural": "If patient1 has a poor metabolizer status, then a pharmacogenetic response occurs in patient1."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(-A30 -> A31) -> A32) -> A34)",
            "(A34 -> A33)"
          ],
          "conclusion": "(-(-(-A30 -> A31) -> A32) -> A33)",
          "natural": "If it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', then a pharmacogenetic response occurs in patient1."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-A30 -> A31) -> A32) -> A33)",
            "(-(-(-A30 -> A31) -> A32) -> -A33)"
          ],
          "conclusion": "(-(-A30 -> A31) -> A32)",
          "natural": "Whenever it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', a genetic variant (allele1) is found in patient1."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-A30 -> A31) -> A32)",
            "-A32"
          ],
          "conclusion": "(-A30 -> A31)",
          "natural": "If a biological sample is not collected from patient1, then lab1 analyzes biomarker sample1."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A30 -> A31)",
            "(-A30 -> -A31)"
          ],
          "conclusion": "A30",
          "natural": "A biological sample (blood) is collected from patient1."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A30 -> G)",
            "A30"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A42 | (A40 | A41))",
            "-A42"
          ],
          "conclusion": "(A40 | A41)",
          "natural": "Patient1 completes the AUDIT-C questionnaire, or clinician1 conducts an interview with patient1."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A40 | A41)",
            "(A40 -> -A39)",
            "(A41 -> -A39)"
          ],
          "conclusion": "-A39",
          "natural": "Data is not missing for patient1."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A38 -> (-G -> A7)) -> A39)",
            "-A39"
          ],
          "conclusion": "(A38 -> (-G -> A7))",
          "natural": "Provided that patient1 wears a sensor, if the treatment in trial1 is not effective, patient1 shows abstinence."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A37 | A38)",
            "(A37 -> (-G -> A7))",
            "(A38 -> (-G -> A7))"
          ],
          "conclusion": "(-G -> A7)",
          "natural": "If the treatment in trial1 is not effective, then patient1 shows abstinence."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A7)",
            "(-G -> -A7)"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A46 | (-A44 -> A45))",
            "-A46"
          ],
          "conclusion": "(-A44 -> A45)",
          "natural": "If the protocol for trial1 is not amended to version2, then recruitment for trial1 is paused."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A44 -> A45)",
            "(-A44 -> -A45)"
          ],
          "conclusion": "A44",
          "natural": "The protocol for trial1 is amended to version2."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A44 -> (A43 -> (-(A17 -> -A15) -> -A18)))",
            "A44"
          ],
          "conclusion": "(A43 -> (-(A17 -> -A15) -> -A18))",
          "natural": "If committee1 (DSMB) reviews trial1, then provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A19 -> A43)",
            "(A43 -> (-(A17 -> -A15) -> -A18))"
          ],
          "conclusion": "(A19 -> (-(A17 -> -A15) -> -A18))",
          "natural": "Whenever the ethics board (IRB) approves trial1, then if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A19 -> (-(A17 -> -A15) -> -A18))",
            "A19"
          ],
          "conclusion": "(-(A17 -> -A15) -> -A18)",
          "natural": "Provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A17 -> -A15) -> A18)",
            "(-(A17 -> -A15) -> -A18)"
          ],
          "conclusion": "(A17 -> -A15)",
          "natural": "If statistician1 performs an interim analysis for trial1, then a protocol violation does not occur in trial1."
        },
        {
          "step_number": 7,
          "rule_applied": "DE",
          "premises_used": [
            "(A16 | A17)",
            "(A16 -> -A15)",
            "(A17 -> -A15)"
          ],
          "conclusion": "-A15",
          "natural": "A protocol violation does not occur in trial1."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A15 | (A14 | G))",
            "-A15"
          ],
          "conclusion": "(A14 | G)",
          "natural": "Either the data for trial1 is audited, or the treatment in trial1 is effective."
        },
        {
          "step_number": 9,
          "rule_applied": "DS",
          "premises_used": [
            "(A14 | G)",
            "-A14"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A49 | (A47 -> (A25 -> (A23 | A24))))",
            "-A49"
          ],
          "conclusion": "(A47 -> (A25 -> (A23 | A24)))",
          "natural": "Provided that patient1 completes the 6-month follow-up, if patient1 meets the primary endpoint, then patient1 receives an intervention or gets support."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A47 | A48)",
            "(A47 -> (A25 -> (A23 | A24)))",
            "(A48 -> (A25 -> (A23 | A24)))"
          ],
          "conclusion": "(A25 -> (A23 | A24))",
          "natural": "If patient1 meets the primary endpoint, then patient1 receives an intervention or gets support."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A25 -> (A23 | A24))",
            "A25"
          ],
          "conclusion": "(A23 | A24)",
          "natural": "Patient1 receives an intervention, or patient1 gets support."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A23 -> A21)",
            "(A24 -> A22)",
            "(A23 | A24)"
          ],
          "conclusion": "(A21 | A22)",
          "natural": "Craving is reduced for patient1, or consumption is decreased for patient1."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            "(A21 | A22)",
            "(A21 -> G)",
            "(A22 -> G)"
          ],
          "conclusion": "G",
          "natural": "The treatment in trial1 is effective."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Clinical Trial on Alcohol Use Disorder",
    "atomic_facts": {
      "A1": "participant_completes(patient1, trial1)",
      "A2": "experiences_side_effect(patient1, nausea)",
      "A3": "reports_adverse_event(patient1, headache)",
      "A4": "receives_placebo(patient1)",
      "A5": "is_randomized(patient1, groupA)",
      "A6": "has_contraindication(patient1, liver_condition)",
      "A7": "shows_abstinence(patient1)",
      "A8": "takes_study_drug(patient1, naltrexone)",
      "A9": "receives_counseling(patient1)",
      "A10": "adheres_to_protocol(patient1)",
      "A11": "attends_visits(patient1)",
      "A12": "investigator_blinded(researcher1)",
      "A13": "coordinator_blinded(nurse1)",
      "A14": "data_audited(trial1)",
      "A15": "protocol_violation_occurs(trial1)",
      "A16": "monitoring_conducted(monitor1, trial1)",
      "A17": "interim_analysis_done(statistician1, trial1)",
      "A18": "trial_halted(trial1)",
      "A19": "irb_approves(ethics_board, trial1)",
      "A20": "fda_approves(agency, trial1)",
      "A21": "craving_reduced(patient1)",
      "A22": "consumption_decreased(patient1)",
      "A23": "receives_intervention(patient1)",
      "A24": "gets_support(patient1)",
      "A25": "primary_endpoint_met(patient1)",
      "A26": "secondary_endpoint_met(patient1)",
      "A27": "statistical_significance_reached(trial1, outcome1)",
      "A28": "paper_published(trial1, journal1)",
      "A29": "results_presented(trial1, conference1)",
      "A30": "biological_sample_collected(patient1, blood)",
      "A31": "biomarker_analyzed(lab1, sample1)",
      "A32": "genetic_variant_found(patient1, allele1)",
      "A33": "pharmacogenetic_response(patient1)",
      "A34": "metabolizer_status(patient1, poor)",
      "A35": "dose_adjusted(patient1)",
      "A36": "ema_reviews(agency_eu, trial1)",
      "A37": "uses_diary(patient1)",
      "A38": "wears_sensor(patient1)",
      "A39": "data_missing(patient1)",
      "A40": "questionnaire_completed(patient1, audit_c)",
      "A41": "interview_conducted(clinician1, patient1)",
      "A42": "funding_continued(grant1)",
      "A43": "dsmb_reviews(committee1, trial1)",
      "A44": "protocol_amended(trial1, version2)",
      "A45": "recruitment_paused(trial1)",
      "A46": "multicenter_expansion(trial1)",
      "A47": "follow_up_completed(patient1, month6)",
      "A48": "long_term_data_collected(patient1, year1)",
      "A49": "replication_study_initiated(trial2)",
      "G": "treatment_effective(trial1)"
    },
    "natural_facts": {
      "A1": "Patient1 completes trial1.",
      "A2": "Patient1 experiences nausea as a side effect.",
      "A3": "Patient1 reports a headache as an adverse event.",
      "A4": "Patient1 receives a placebo.",
      "A5": "Patient1 is randomized into groupA.",
      "A6": "Patient1 has a contraindication: a liver condition.",
      "A7": "Patient1 shows abstinence.",
      "A8": "Patient1 takes the study drug, naltrexone.",
      "A9": "Patient1 receives counseling.",
      "A10": "Patient1 adheres to the protocol.",
      "A11": "Patient1 attends the study visits.",
      "A12": "Researcher1 is blinded as an investigator.",
      "A13": "Nurse1 is blinded as a coordinator.",
      "A14": "The data for trial1 is audited.",
      "A15": "A protocol violation occurs in trial1.",
      "A16": "Monitor1 conducts monitoring for trial1.",
      "A17": "Statistician1 performs an interim analysis for trial1.",
      "A18": "Trial1 is halted.",
      "A19": "The ethics board (IRB) approves trial1.",
      "A20": "The agency (FDA) approves trial1.",
      "A21": "Craving is reduced for patient1.",
      "A22": "Consumption is decreased for patient1.",
      "A23": "Patient1 receives an intervention.",
      "A24": "Patient1 gets support.",
      "A25": "Patient1 meets the primary endpoint.",
      "A26": "Patient1 meets the secondary endpoint.",
      "A27": "Statistical significance for outcome1 is reached in trial1.",
      "A28": "A paper for trial1 is published in journal1.",
      "A29": "The results of trial1 are presented at conference1.",
      "A30": "A biological sample (blood) is collected from patient1.",
      "A31": "Lab1 analyzes biomarker sample1.",
      "A32": "A genetic variant (allele1) is found in patient1.",
      "A33": "A pharmacogenetic response occurs in patient1.",
      "A34": "Patient1 has a poor metabolizer status.",
      "A35": "The dose for patient1 is adjusted.",
      "A36": "The European agency (EMA) reviews trial1.",
      "A37": "Patient1 uses a diary.",
      "A38": "Patient1 wears a sensor.",
      "A39": "Data is missing for patient1.",
      "A40": "Patient1 completes the AUDIT-C questionnaire.",
      "A41": "Clinician1 conducts an interview with patient1.",
      "A42": "Grant1 funding is continued.",
      "A43": "Committee1 (DSMB) reviews trial1.",
      "A44": "The protocol for trial1 is amended to version2.",
      "A45": "Recruitment for trial1 is paused.",
      "A46": "Trial1 undergoes a multicenter expansion.",
      "A47": "Patient1 completes the 6-month follow-up.",
      "A48": "Long-term data is collected from patient1 at year1.",
      "A49": "Replication study trial2 is initiated.",
      "G": "The treatment in trial1 is effective."
    },
    "prover9_expressions": [
      "(participant_completes(patient1, trial1) -> treatment_effective(trial1))",
      "(adheres_to_protocol(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
      "(attends_visits(patient1) -> adheres_to_protocol(patient1))",
      "(investigator_blinded(researcher1) -> (attends_visits(patient1) -> adheres_to_protocol(patient1)))",
      "(investigator_blinded(researcher1) | coordinator_blinded(nurse1))",
      "(coordinator_blinded(nurse1) -> (attends_visits(patient1) -> adheres_to_protocol(patient1)))",
      "(data_audited(trial1) | treatment_effective(trial1))",
      "(protocol_violation_occurs(trial1) | (data_audited(trial1) | treatment_effective(trial1)))",
      "(monitoring_conducted(monitor1, trial1) -> -protocol_violation_occurs(trial1))",
      "(monitoring_conducted(monitor1, trial1) | interim_analysis_done(statistician1, trial1))",
      "(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1))",
      "(irb_approves(ethics_board, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
      "(irb_approves(ethics_board, trial1) -> fda_approves(agency, trial1))",
      "(irb_approves(ethics_board, trial1) -> dsmb_reviews(committee1, trial1))",
      "(fda_approves(agency, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
      "(craving_reduced(patient1) -> treatment_effective(trial1))",
      "(craving_reduced(patient1) | consumption_decreased(patient1))",
      "(consumption_decreased(patient1) -> treatment_effective(trial1))",
      "(receives_intervention(patient1) -> craving_reduced(patient1))",
      "(receives_intervention(patient1) | gets_support(patient1))",
      "(gets_support(patient1) -> consumption_decreased(patient1))",
      "(primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))",
      "(primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))",
      "(secondary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))",
      "(statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1)))",
      "(paper_published(trial1, journal1) -> (statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))))",
      "(paper_published(trial1, journal1) | results_presented(trial1, conference1))",
      "(results_presented(trial1, conference1) -> (statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))))",
      "(reports_adverse_event(patient1, headache) -> -experiences_side_effect(patient1, nausea))",
      "(biological_sample_collected(patient1, blood) -> treatment_effective(trial1))",
      "(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1))",
      "(ema_reviews(agency_eu, trial1) -> (-(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1)) -> dose_adjusted(patient1)))",
      "(uses_diary(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
      "(uses_diary(patient1) | wears_sensor(patient1))",
      "(wears_sensor(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
      "(receives_placebo(patient1) -> (reports_adverse_event(patient1, headache) -> -experiences_side_effect(patient1, nausea)))",
      "(questionnaire_completed(patient1, audit_c) -> -data_missing(patient1))",
      "(questionnaire_completed(patient1, audit_c) | interview_conducted(clinician1, patient1))",
      "(interview_conducted(clinician1, patient1) -> -data_missing(patient1))",
      "(funding_continued(grant1) | (questionnaire_completed(patient1, audit_c) | interview_conducted(clinician1, patient1)))",
      "(dsmb_reviews(committee1, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
      "(protocol_amended(trial1, version2) -> (dsmb_reviews(committee1, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1))))",
      "(multicenter_expansion(trial1) | (-protocol_amended(trial1, version2) -> recruitment_paused(trial1)))",
      "(follow_up_completed(patient1, month6) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1))))",
      "(follow_up_completed(patient1, month6) | long_term_data_collected(patient1, year1))",
      "(long_term_data_collected(patient1, year1) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1))))",
      "(replication_study_initiated(trial2) | (follow_up_completed(patient1, month6) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))))",
      "(is_randomized(patient1, groupA) -> receives_placebo(patient1))",
      "(has_contraindication(patient1, liver_condition) | (is_randomized(patient1, groupA) -> receives_placebo(patient1)))",
      "(takes_study_drug(patient1, naltrexone) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
      "(takes_study_drug(patient1, naltrexone) -> adheres_to_protocol(patient1))",
      "(takes_study_drug(patient1, naltrexone) -> attends_visits(patient1))",
      "(takes_study_drug(patient1, naltrexone) | receives_counseling(patient1))",
      "(receives_counseling(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
      "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> experiences_side_effect(patient1, nausea))",
      "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> reports_adverse_event(patient1, headache))",
      "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> -experiences_side_effect(patient1, nausea))",
      "(-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> trial_halted(trial1))",
      "(-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1))",
      "(-(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1)) -> dose_adjusted(patient1))",
      "(-(wears_sensor(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1))) -> data_missing(patient1))",
      "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> pharmacogenetic_response(patient1))",
      "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> metabolizer_status(patient1, poor))",
      "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> -pharmacogenetic_response(patient1))",
      "(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1))",
      "(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1))",
      "(-biological_sample_collected(patient1, blood) -> -biomarker_analyzed(lab1, sample1))",
      "(-protocol_amended(trial1, version2) -> recruitment_paused(trial1))",
      "(-protocol_amended(trial1, version2) -> -recruitment_paused(trial1))",
      "(-treatment_effective(trial1) -> shows_abstinence(patient1))",
      "(-treatment_effective(trial1) -> -shows_abstinence(patient1))",
      "participant_completes(patient1, trial1)",
      "irb_approves(ethics_board, trial1)",
      "primary_endpoint_met(patient1)",
      "statistical_significance_reached(trial1, outcome1)",
      "biological_sample_collected(patient1, blood)",
      "ema_reviews(agency_eu, trial1)",
      "receives_placebo(patient1)",
      "protocol_amended(trial1, version2)",
      "is_randomized(patient1, groupA)",
      "treatment_effective(trial1)",
      "-data_audited(trial1)",
      "-protocol_violation_occurs(trial1)",
      "-genetic_variant_found(patient1, allele1)",
      "-dose_adjusted(patient1)",
      "-data_missing(patient1)",
      "-funding_continued(grant1)",
      "-multicenter_expansion(trial1)",
      "-replication_study_initiated(trial2)",
      "-has_contraindication(patient1, liver_condition)"
    ],
    "natural_expressions": [
      "If patient1 completes trial1, then the treatment in trial1 is effective.",
      "Provided that patient1 adheres to the protocol, if the treatment in trial1 is not effective, then patient1 shows abstinence.",
      "Under the condition that patient1 attends the study visits, patient1 adheres to the protocol.",
      "If researcher1 is blinded as an investigator, then whenever patient1 attends the study visits, patient1 adheres to the protocol.",
      "Either researcher1 is blinded as an investigator or nurse1 is blinded as a coordinator.",
      "If nurse1 is blinded as a coordinator, then given that patient1 attends the study visits, patient1 adheres to the protocol.",
      "Either the data for trial1 is audited, or the treatment in trial1 is effective.",
      "A protocol violation occurs in trial1, or the data for trial1 is audited, or the treatment in trial1 is effective.",
      "Provided that monitor1 conducts monitoring for trial1, a protocol violation does not occur in trial1.",
      "Monitor1 conducts monitoring for trial1, or statistician1 performs an interim analysis for trial1.",
      "If statistician1 performs an interim analysis for trial1, then a protocol violation does not occur in trial1.",
      "Whenever the ethics board (IRB) approves trial1, then if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted.",
      "If the ethics board (IRB) approves trial1, then the agency (FDA) approves trial1.",
      "If the ethics board (IRB) approves trial1, then committee1 (DSMB) reviews trial1.",
      "If the agency (FDA) approves trial1, then provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted.",
      "If craving is reduced for patient1, then the treatment in trial1 is effective.",
      "Craving is reduced for patient1, or consumption is decreased for patient1.",
      "Provided that consumption is decreased for patient1, the treatment in trial1 is effective.",
      "If patient1 receives an intervention, then craving is reduced for patient1.",
      "Patient1 receives an intervention, or patient1 gets support.",
      "Under the condition that patient1 gets support, consumption is decreased for patient1.",
      "If patient1 meets the primary endpoint, then patient1 receives an intervention or gets support.",
      "Whenever patient1 meets the primary endpoint, patient1 meets the secondary endpoint.",
      "If patient1 meets the secondary endpoint, then patient1 receives an intervention or gets support.",
      "Provided that statistical significance for outcome1 is reached in trial1, then if patient1 meets the primary endpoint, patient1 meets the secondary endpoint.",
      "If a paper for trial1 is published in journal1, then given that statistical significance is reached, if patient1 meets the primary endpoint, patient1 meets the secondary endpoint.",
      "A paper for trial1 is published in journal1, or the results of trial1 are presented at conference1.",
      "If the results of trial1 are presented at conference1, then under the condition that statistical significance is reached, if patient1 meets the primary endpoint, patient1 meets the secondary endpoint.",
      "If patient1 reports a headache as an adverse event, then patient1 does not experience nausea as a side effect.",
      "Provided that a biological sample (blood) is collected from patient1, the treatment in trial1 is effective.",
      "If patient1 has a poor metabolizer status, then a pharmacogenetic response occurs in patient1.",
      "Whenever the European agency (EMA) reviews trial1, then if it is not the case that 'if patient1 has a poor metabolizer status, then a pharmacogenetic response occurs', the dose for patient1 is adjusted.",
      "If patient1 uses a diary, then if the treatment in trial1 is not effective, patient1 shows abstinence.",
      "Patient1 uses a diary, or patient1 wears a sensor.",
      "Provided that patient1 wears a sensor, if the treatment in trial1 is not effective, patient1 shows abstinence.",
      "If patient1 receives a placebo, then whenever patient1 reports a headache as an adverse event, patient1 does not experience nausea as a side effect.",
      "If patient1 completes the AUDIT-C questionnaire, then data is not missing for patient1.",
      "Patient1 completes the AUDIT-C questionnaire, or clinician1 conducts an interview with patient1.",
      "Under the condition that clinician1 conducts an interview with patient1, data is not missing for patient1.",
      "Grant1 funding is continued, or patient1 completes the AUDIT-C questionnaire, or clinician1 conducts an interview with patient1.",
      "If committee1 (DSMB) reviews trial1, then provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted.",
      "If the protocol for trial1 is amended to version2, then given that committee1 (DSMB) reviews trial1, if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted.",
      "Trial1 undergoes a multicenter expansion, or if the protocol for trial1 is not amended to version2, then recruitment for trial1 is paused.",
      "Provided that patient1 completes the 6-month follow-up, if patient1 meets the primary endpoint, then patient1 receives an intervention or gets support.",
      "Patient1 completes the 6-month follow-up, or long-term data is collected from patient1 at year1.",
      "If long-term data is collected from patient1 at year1, then whenever patient1 meets the primary endpoint, patient1 receives an intervention or gets support.",
      "Replication study trial2 is initiated, or if patient1 completes the 6-month follow-up, then given that patient1 meets the primary endpoint, patient1 receives an intervention or gets support.",
      "If patient1 is randomized into groupA, then patient1 receives a placebo.",
      "Patient1 has a contraindication (a liver condition), or if patient1 is randomized into groupA, then patient1 receives a placebo.",
      "Provided that patient1 takes the study drug, naltrexone, if the treatment in trial1 is not effective, then patient1 shows abstinence.",
      "If patient1 takes the study drug, naltrexone, then patient1 adheres to the protocol.",
      "If patient1 takes the study drug, naltrexone, then patient1 attends the study visits.",
      "Patient1 takes the study drug, naltrexone, or patient1 receives counseling.",
      "Under the condition that patient1 receives counseling, if the treatment in trial1 is not effective, then patient1 shows abstinence.",
      "If it is not the case that 'if patient1 completes trial1, then the treatment is effective', then patient1 experiences nausea as a side effect.",
      "Provided that it is not the case that 'if patient1 completes trial1, then the treatment is effective', patient1 reports a headache as an adverse event.",
      "If it is not the case that 'if patient1 completes trial1, then the treatment is effective', then patient1 does not experience nausea as a side effect.",
      "Whenever it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is halted.",
      "Provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted.",
      "If it is not the case that 'if patient1 has a poor metabolizer status, then a pharmacogenetic response occurs', then the dose for patient1 is adjusted.",
      "Under the condition that it is not the case that 'if patient1 wears a sensor, then if the treatment is not effective, patient1 shows abstinence', data is missing for patient1.",
      "If it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', then a pharmacogenetic response occurs in patient1.",
      "Provided that it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', patient1 has a poor metabolizer status.",
      "If it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', then a pharmacogenetic response does not occur in patient1.",
      "Whenever it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', a genetic variant (allele1) is found in patient1.",
      "If a biological sample is not collected from patient1, then lab1 analyzes biomarker sample1.",
      "Provided that a biological sample is not collected from patient1, lab1 does not analyze biomarker sample1.",
      "If the protocol for trial1 is not amended to version2, then recruitment for trial1 is paused.",
      "Under the condition that the protocol for trial1 is not amended to version2, recruitment for trial1 is not paused.",
      "If the treatment in trial1 is not effective, then patient1 shows abstinence.",
      "Provided that the treatment in trial1 is not effective, patient1 does not show abstinence.",
      "Patient1 completes trial1.",
      "The ethics board (IRB) approves trial1.",
      "Patient1 meets the primary endpoint.",
      "Statistical significance for outcome1 is reached in trial1.",
      "A biological sample (blood) is collected from patient1.",
      "The European agency (EMA) reviews trial1.",
      "Patient1 receives a placebo.",
      "The protocol for trial1 is amended to version2.",
      "Patient1 is randomized into groupA.",
      "The treatment in trial1 is effective.",
      "It is not the case that the data for trial1 is audited.",
      "A protocol violation does not occur in trial1.",
      "A genetic variant (allele1) is not found in patient1.",
      "The dose for patient1 is not adjusted.",
      "Data is not missing for patient1.",
      "Grant1 funding is not continued.",
      "Trial1 does not undergo a multicenter expansion.",
      "Replication study trial2 is not initiated.",
      "Patient1 does not have a contraindication: a liver condition."
    ],
    "node_mappings": {
      "(A1 → G)": {
        "formal": "(A1 → G)",
        "prover9": "(A1 -> G)",
        "prover9_expression": "(participant_completes(patient1, trial1) -> treatment_effective(trial1))",
        "natural": "If patient1 completes trial1, then the treatment in trial1 is effective."
      },
      "(A10 → (¬G → A7))": {
        "formal": "(A10 → (¬G → A7))",
        "prover9": "(A10 -> (-G -> A7))",
        "prover9_expression": "(adheres_to_protocol(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "Provided that patient1 adheres to the protocol, if the treatment in trial1 is not effective, then patient1 shows abstinence."
      },
      "(A11 → A10)": {
        "formal": "(A11 → A10)",
        "prover9": "(A11 -> A10)",
        "prover9_expression": "(attends_visits(patient1) -> adheres_to_protocol(patient1))",
        "natural": "Under the condition that patient1 attends the study visits, patient1 adheres to the protocol."
      },
      "(A12 → (A11 → A10))": {
        "formal": "(A12 → (A11 → A10))",
        "prover9": "(A12 -> (A11 -> A10))",
        "prover9_expression": "(investigator_blinded(researcher1) -> (attends_visits(patient1) -> adheres_to_protocol(patient1)))",
        "natural": "If researcher1 is blinded as an investigator, then whenever patient1 attends the study visits, patient1 adheres to the protocol."
      },
      "(A12 ∨ A13)": {
        "formal": "(A12 ∨ A13)",
        "prover9": "(A12 | A13)",
        "prover9_expression": "(investigator_blinded(researcher1) | coordinator_blinded(nurse1))",
        "natural": "Either researcher1 is blinded as an investigator or nurse1 is blinded as a coordinator."
      },
      "(A13 → (A11 → A10))": {
        "formal": "(A13 → (A11 → A10))",
        "prover9": "(A13 -> (A11 -> A10))",
        "prover9_expression": "(coordinator_blinded(nurse1) -> (attends_visits(patient1) -> adheres_to_protocol(patient1)))",
        "natural": "If nurse1 is blinded as a coordinator, then given that patient1 attends the study visits, patient1 adheres to the protocol."
      },
      "(A14 ∨ G)": {
        "formal": "(A14 ∨ G)",
        "prover9": "(A14 | G)",
        "prover9_expression": "(data_audited(trial1) | treatment_effective(trial1))",
        "natural": "Either the data for trial1 is audited, or the treatment in trial1 is effective."
      },
      "(A15 ∨ (A14 ∨ G))": {
        "formal": "(A15 ∨ (A14 ∨ G))",
        "prover9": "(A15 | (A14 | G))",
        "prover9_expression": "(protocol_violation_occurs(trial1) | (data_audited(trial1) | treatment_effective(trial1)))",
        "natural": "A protocol violation occurs in trial1, or the data for trial1 is audited, or the treatment in trial1 is effective."
      },
      "(A16 → ¬A15)": {
        "formal": "(A16 → ¬A15)",
        "prover9": "(A16 -> -A15)",
        "prover9_expression": "(monitoring_conducted(monitor1, trial1) -> -protocol_violation_occurs(trial1))",
        "natural": "Provided that monitor1 conducts monitoring for trial1, a protocol violation does not occur in trial1."
      },
      "(A16 ∨ A17)": {
        "formal": "(A16 ∨ A17)",
        "prover9": "(A16 | A17)",
        "prover9_expression": "(monitoring_conducted(monitor1, trial1) | interim_analysis_done(statistician1, trial1))",
        "natural": "Monitor1 conducts monitoring for trial1, or statistician1 performs an interim analysis for trial1."
      },
      "(A17 → ¬A15)": {
        "formal": "(A17 → ¬A15)",
        "prover9": "(A17 -> -A15)",
        "prover9_expression": "(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1))",
        "natural": "If statistician1 performs an interim analysis for trial1, then a protocol violation does not occur in trial1."
      },
      "(A19 → (¬(A17 → ¬A15) → ¬A18))": {
        "formal": "(A19 → (¬(A17 → ¬A15) → ¬A18))",
        "prover9": "(A19 -> (-(A17 -> -A15) -> -A18))",
        "prover9_expression": "(irb_approves(ethics_board, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
        "natural": "Whenever the ethics board (IRB) approves trial1, then if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      "(A19 → A20)": {
        "formal": "(A19 → A20)",
        "prover9": "(A19 -> A20)",
        "prover9_expression": "(irb_approves(ethics_board, trial1) -> fda_approves(agency, trial1))",
        "natural": "If the ethics board (IRB) approves trial1, then the agency (FDA) approves trial1."
      },
      "(A19 → A43)": {
        "formal": "(A19 → A43)",
        "prover9": "(A19 -> A43)",
        "prover9_expression": "(irb_approves(ethics_board, trial1) -> dsmb_reviews(committee1, trial1))",
        "natural": "If the ethics board (IRB) approves trial1, then committee1 (DSMB) reviews trial1."
      },
      "(A20 → (¬(A17 → ¬A15) → ¬A18))": {
        "formal": "(A20 → (¬(A17 → ¬A15) → ¬A18))",
        "prover9": "(A20 -> (-(A17 -> -A15) -> -A18))",
        "prover9_expression": "(fda_approves(agency, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
        "natural": "If the agency (FDA) approves trial1, then provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      "(A21 → G)": {
        "formal": "(A21 → G)",
        "prover9": "(A21 -> G)",
        "prover9_expression": "(craving_reduced(patient1) -> treatment_effective(trial1))",
        "natural": "If craving is reduced for patient1, then the treatment in trial1 is effective."
      },
      "(A21 ∨ A22)": {
        "formal": "(A21 ∨ A22)",
        "prover9": "(A21 | A22)",
        "prover9_expression": "(craving_reduced(patient1) | consumption_decreased(patient1))",
        "natural": "Craving is reduced for patient1, or consumption is decreased for patient1."
      },
      "(A22 → G)": {
        "formal": "(A22 → G)",
        "prover9": "(A22 -> G)",
        "prover9_expression": "(consumption_decreased(patient1) -> treatment_effective(trial1))",
        "natural": "Provided that consumption is decreased for patient1, the treatment in trial1 is effective."
      },
      "(A23 → A21)": {
        "formal": "(A23 → A21)",
        "prover9": "(A23 -> A21)",
        "prover9_expression": "(receives_intervention(patient1) -> craving_reduced(patient1))",
        "natural": "If patient1 receives an intervention, then craving is reduced for patient1."
      },
      "(A23 ∨ A24)": {
        "formal": "(A23 ∨ A24)",
        "prover9": "(A23 | A24)",
        "prover9_expression": "(receives_intervention(patient1) | gets_support(patient1))",
        "natural": "Patient1 receives an intervention, or patient1 gets support."
      },
      "(A24 → A22)": {
        "formal": "(A24 → A22)",
        "prover9": "(A24 -> A22)",
        "prover9_expression": "(gets_support(patient1) -> consumption_decreased(patient1))",
        "natural": "Under the condition that patient1 gets support, consumption is decreased for patient1."
      },
      "(A25 → (A23 ∨ A24))": {
        "formal": "(A25 → (A23 ∨ A24))",
        "prover9": "(A25 -> (A23 | A24))",
        "prover9_expression": "(primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))",
        "natural": "If patient1 meets the primary endpoint, then patient1 receives an intervention or gets support."
      },
      "(A25 → A26)": {
        "formal": "(A25 → A26)",
        "prover9": "(A25 -> A26)",
        "prover9_expression": "(primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))",
        "natural": "Whenever patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
      },
      "(A26 → (A23 ∨ A24))": {
        "formal": "(A26 → (A23 ∨ A24))",
        "prover9": "(A26 -> (A23 | A24))",
        "prover9_expression": "(secondary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))",
        "natural": "If patient1 meets the secondary endpoint, then patient1 receives an intervention or gets support."
      },
      "(A27 → (A25 → A26))": {
        "formal": "(A27 → (A25 → A26))",
        "prover9": "(A27 -> (A25 -> A26))",
        "prover9_expression": "(statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1)))",
        "natural": "Provided that statistical significance for outcome1 is reached in trial1, then if patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
      },
      "(A28 → (A27 → (A25 → A26)))": {
        "formal": "(A28 → (A27 → (A25 → A26)))",
        "prover9": "(A28 -> (A27 -> (A25 -> A26)))",
        "prover9_expression": "(paper_published(trial1, journal1) -> (statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))))",
        "natural": "If a paper for trial1 is published in journal1, then given that statistical significance is reached, if patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
      },
      "(A28 ∨ A29)": {
        "formal": "(A28 ∨ A29)",
        "prover9": "(A28 | A29)",
        "prover9_expression": "(paper_published(trial1, journal1) | results_presented(trial1, conference1))",
        "natural": "A paper for trial1 is published in journal1, or the results of trial1 are presented at conference1."
      },
      "(A29 → (A27 → (A25 → A26)))": {
        "formal": "(A29 → (A27 → (A25 → A26)))",
        "prover9": "(A29 -> (A27 -> (A25 -> A26)))",
        "prover9_expression": "(results_presented(trial1, conference1) -> (statistical_significance_reached(trial1, outcome1) -> (primary_endpoint_met(patient1) -> secondary_endpoint_met(patient1))))",
        "natural": "If the results of trial1 are presented at conference1, then under the condition that statistical significance is reached, if patient1 meets the primary endpoint, patient1 meets the secondary endpoint."
      },
      "(A3 → ¬A2)": {
        "formal": "(A3 → ¬A2)",
        "prover9": "(A3 -> -A2)",
        "prover9_expression": "(reports_adverse_event(patient1, headache) -> -experiences_side_effect(patient1, nausea))",
        "natural": "If patient1 reports a headache as an adverse event, then patient1 does not experience nausea as a side effect."
      },
      "(A30 → G)": {
        "formal": "(A30 → G)",
        "prover9": "(A30 -> G)",
        "prover9_expression": "(biological_sample_collected(patient1, blood) -> treatment_effective(trial1))",
        "natural": "Provided that a biological sample (blood) is collected from patient1, the treatment in trial1 is effective."
      },
      "(A34 → A33)": {
        "formal": "(A34 → A33)",
        "prover9": "(A34 -> A33)",
        "prover9_expression": "(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1))",
        "natural": "If patient1 has a poor metabolizer status, then a pharmacogenetic response occurs in patient1."
      },
      "(A36 → (¬(A34 → A33) → A35))": {
        "formal": "(A36 → (¬(A34 → A33) → A35))",
        "prover9": "(A36 -> (-(A34 -> A33) -> A35))",
        "prover9_expression": "(ema_reviews(agency_eu, trial1) -> (-(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1)) -> dose_adjusted(patient1)))",
        "natural": "Whenever the European agency (EMA) reviews trial1, then if it is not the case that 'if patient1 has a poor metabolizer status, then a pharmacogenetic response occurs', the dose for patient1 is adjusted."
      },
      "(A37 → (¬G → A7))": {
        "formal": "(A37 → (¬G → A7))",
        "prover9": "(A37 -> (-G -> A7))",
        "prover9_expression": "(uses_diary(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "If patient1 uses a diary, then if the treatment in trial1 is not effective, patient1 shows abstinence."
      },
      "(A37 ∨ A38)": {
        "formal": "(A37 ∨ A38)",
        "prover9": "(A37 | A38)",
        "prover9_expression": "(uses_diary(patient1) | wears_sensor(patient1))",
        "natural": "Patient1 uses a diary, or patient1 wears a sensor."
      },
      "(A38 → (¬G → A7))": {
        "formal": "(A38 → (¬G → A7))",
        "prover9": "(A38 -> (-G -> A7))",
        "prover9_expression": "(wears_sensor(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "Provided that patient1 wears a sensor, if the treatment in trial1 is not effective, patient1 shows abstinence."
      },
      "(A4 → (A3 → ¬A2))": {
        "formal": "(A4 → (A3 → ¬A2))",
        "prover9": "(A4 -> (A3 -> -A2))",
        "prover9_expression": "(receives_placebo(patient1) -> (reports_adverse_event(patient1, headache) -> -experiences_side_effect(patient1, nausea)))",
        "natural": "If patient1 receives a placebo, then whenever patient1 reports a headache as an adverse event, patient1 does not experience nausea as a side effect."
      },
      "(A40 → ¬A39)": {
        "formal": "(A40 → ¬A39)",
        "prover9": "(A40 -> -A39)",
        "prover9_expression": "(questionnaire_completed(patient1, audit_c) -> -data_missing(patient1))",
        "natural": "If patient1 completes the AUDIT-C questionnaire, then data is not missing for patient1."
      },
      "(A40 ∨ A41)": {
        "formal": "(A40 ∨ A41)",
        "prover9": "(A40 | A41)",
        "prover9_expression": "(questionnaire_completed(patient1, audit_c) | interview_conducted(clinician1, patient1))",
        "natural": "Patient1 completes the AUDIT-C questionnaire, or clinician1 conducts an interview with patient1."
      },
      "(A41 → ¬A39)": {
        "formal": "(A41 → ¬A39)",
        "prover9": "(A41 -> -A39)",
        "prover9_expression": "(interview_conducted(clinician1, patient1) -> -data_missing(patient1))",
        "natural": "Under the condition that clinician1 conducts an interview with patient1, data is not missing for patient1."
      },
      "(A42 ∨ (A40 ∨ A41))": {
        "formal": "(A42 ∨ (A40 ∨ A41))",
        "prover9": "(A42 | (A40 | A41))",
        "prover9_expression": "(funding_continued(grant1) | (questionnaire_completed(patient1, audit_c) | interview_conducted(clinician1, patient1)))",
        "natural": "Grant1 funding is continued, or patient1 completes the AUDIT-C questionnaire, or clinician1 conducts an interview with patient1."
      },
      "(A43 → (¬(A17 → ¬A15) → ¬A18))": {
        "formal": "(A43 → (¬(A17 → ¬A15) → ¬A18))",
        "prover9": "(A43 -> (-(A17 -> -A15) -> -A18))",
        "prover9_expression": "(dsmb_reviews(committee1, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1)))",
        "natural": "If committee1 (DSMB) reviews trial1, then provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      "(A44 → (A43 → (¬(A17 → ¬A15) → ¬A18)))": {
        "formal": "(A44 → (A43 → (¬(A17 → ¬A15) → ¬A18)))",
        "prover9": "(A44 -> (A43 -> (-(A17 -> -A15) -> -A18)))",
        "prover9_expression": "(protocol_amended(trial1, version2) -> (dsmb_reviews(committee1, trial1) -> (-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1))))",
        "natural": "If the protocol for trial1 is amended to version2, then given that committee1 (DSMB) reviews trial1, if it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      "(A46 ∨ (¬A44 → A45))": {
        "formal": "(A46 ∨ (¬A44 → A45))",
        "prover9": "(A46 | (-A44 -> A45))",
        "prover9_expression": "(multicenter_expansion(trial1) | (-protocol_amended(trial1, version2) -> recruitment_paused(trial1)))",
        "natural": "Trial1 undergoes a multicenter expansion, or if the protocol for trial1 is not amended to version2, then recruitment for trial1 is paused."
      },
      "(A47 → (A25 → (A23 ∨ A24)))": {
        "formal": "(A47 → (A25 → (A23 ∨ A24)))",
        "prover9": "(A47 -> (A25 -> (A23 | A24)))",
        "prover9_expression": "(follow_up_completed(patient1, month6) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1))))",
        "natural": "Provided that patient1 completes the 6-month follow-up, if patient1 meets the primary endpoint, then patient1 receives an intervention or gets support."
      },
      "(A47 ∨ A48)": {
        "formal": "(A47 ∨ A48)",
        "prover9": "(A47 | A48)",
        "prover9_expression": "(follow_up_completed(patient1, month6) | long_term_data_collected(patient1, year1))",
        "natural": "Patient1 completes the 6-month follow-up, or long-term data is collected from patient1 at year1."
      },
      "(A48 → (A25 → (A23 ∨ A24)))": {
        "formal": "(A48 → (A25 → (A23 ∨ A24)))",
        "prover9": "(A48 -> (A25 -> (A23 | A24)))",
        "prover9_expression": "(long_term_data_collected(patient1, year1) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1))))",
        "natural": "If long-term data is collected from patient1 at year1, then whenever patient1 meets the primary endpoint, patient1 receives an intervention or gets support."
      },
      "(A49 ∨ (A47 → (A25 → (A23 ∨ A24))))": {
        "formal": "(A49 ∨ (A47 → (A25 → (A23 ∨ A24))))",
        "prover9": "(A49 | (A47 -> (A25 -> (A23 | A24))))",
        "prover9_expression": "(replication_study_initiated(trial2) | (follow_up_completed(patient1, month6) -> (primary_endpoint_met(patient1) -> (receives_intervention(patient1) | gets_support(patient1)))))",
        "natural": "Replication study trial2 is initiated, or if patient1 completes the 6-month follow-up, then given that patient1 meets the primary endpoint, patient1 receives an intervention or gets support."
      },
      "(A5 → A4)": {
        "formal": "(A5 → A4)",
        "prover9": "(A5 -> A4)",
        "prover9_expression": "(is_randomized(patient1, groupA) -> receives_placebo(patient1))",
        "natural": "If patient1 is randomized into groupA, then patient1 receives a placebo."
      },
      "(A6 ∨ (A5 → A4))": {
        "formal": "(A6 ∨ (A5 → A4))",
        "prover9": "(A6 | (A5 -> A4))",
        "prover9_expression": "(has_contraindication(patient1, liver_condition) | (is_randomized(patient1, groupA) -> receives_placebo(patient1)))",
        "natural": "Patient1 has a contraindication (a liver condition), or if patient1 is randomized into groupA, then patient1 receives a placebo."
      },
      "(A8 → (¬G → A7))": {
        "formal": "(A8 → (¬G → A7))",
        "prover9": "(A8 -> (-G -> A7))",
        "prover9_expression": "(takes_study_drug(patient1, naltrexone) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "Provided that patient1 takes the study drug, naltrexone, if the treatment in trial1 is not effective, then patient1 shows abstinence."
      },
      "(A8 → A10)": {
        "formal": "(A8 → A10)",
        "prover9": "(A8 -> A10)",
        "prover9_expression": "(takes_study_drug(patient1, naltrexone) -> adheres_to_protocol(patient1))",
        "natural": "If patient1 takes the study drug, naltrexone, then patient1 adheres to the protocol."
      },
      "(A8 → A11)": {
        "formal": "(A8 → A11)",
        "prover9": "(A8 -> A11)",
        "prover9_expression": "(takes_study_drug(patient1, naltrexone) -> attends_visits(patient1))",
        "natural": "If patient1 takes the study drug, naltrexone, then patient1 attends the study visits."
      },
      "(A8 ∨ A9)": {
        "formal": "(A8 ∨ A9)",
        "prover9": "(A8 | A9)",
        "prover9_expression": "(takes_study_drug(patient1, naltrexone) | receives_counseling(patient1))",
        "natural": "Patient1 takes the study drug, naltrexone, or patient1 receives counseling."
      },
      "(A9 → (¬G → A7))": {
        "formal": "(A9 → (¬G → A7))",
        "prover9": "(A9 -> (-G -> A7))",
        "prover9_expression": "(receives_counseling(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1)))",
        "natural": "Under the condition that patient1 receives counseling, if the treatment in trial1 is not effective, then patient1 shows abstinence."
      },
      "(¬(A1 → G) → A2)": {
        "formal": "(¬(A1 → G) → A2)",
        "prover9": "(-(A1 -> G) -> A2)",
        "prover9_expression": "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> experiences_side_effect(patient1, nausea))",
        "natural": "If it is not the case that 'if patient1 completes trial1, then the treatment is effective', then patient1 experiences nausea as a side effect."
      },
      "(¬(A1 → G) → A3)": {
        "formal": "(¬(A1 → G) → A3)",
        "prover9": "(-(A1 -> G) -> A3)",
        "prover9_expression": "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> reports_adverse_event(patient1, headache))",
        "natural": "Provided that it is not the case that 'if patient1 completes trial1, then the treatment is effective', patient1 reports a headache as an adverse event."
      },
      "(¬(A1 → G) → ¬A2)": {
        "formal": "(¬(A1 → G) → ¬A2)",
        "prover9": "(-(A1 -> G) -> -A2)",
        "prover9_expression": "(-(participant_completes(patient1, trial1) -> treatment_effective(trial1)) -> -experiences_side_effect(patient1, nausea))",
        "natural": "If it is not the case that 'if patient1 completes trial1, then the treatment is effective', then patient1 does not experience nausea as a side effect."
      },
      "(¬(A17 → ¬A15) → A18)": {
        "formal": "(¬(A17 → ¬A15) → A18)",
        "prover9": "(-(A17 -> -A15) -> A18)",
        "prover9_expression": "(-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> trial_halted(trial1))",
        "natural": "Whenever it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is halted."
      },
      "(¬(A17 → ¬A15) → ¬A18)": {
        "formal": "(¬(A17 → ¬A15) → ¬A18)",
        "prover9": "(-(A17 -> -A15) -> -A18)",
        "prover9_expression": "(-(interim_analysis_done(statistician1, trial1) -> -protocol_violation_occurs(trial1)) -> -trial_halted(trial1))",
        "natural": "Provided that it is not the case that 'if an interim analysis is performed, then a protocol violation does not occur', trial1 is not halted."
      },
      "(¬(A34 → A33) → A35)": {
        "formal": "(¬(A34 → A33) → A35)",
        "prover9": "(-(A34 -> A33) -> A35)",
        "prover9_expression": "(-(metabolizer_status(patient1, poor) -> pharmacogenetic_response(patient1)) -> dose_adjusted(patient1))",
        "natural": "If it is not the case that 'if patient1 has a poor metabolizer status, then a pharmacogenetic response occurs', then the dose for patient1 is adjusted."
      },
      "(¬(A38 → (¬G → A7)) → A39)": {
        "formal": "(¬(A38 → (¬G → A7)) → A39)",
        "prover9": "(-(A38 -> (-G -> A7)) -> A39)",
        "prover9_expression": "(-(wears_sensor(patient1) -> (-treatment_effective(trial1) -> shows_abstinence(patient1))) -> data_missing(patient1))",
        "natural": "Under the condition that it is not the case that 'if patient1 wears a sensor, then if the treatment is not effective, patient1 shows abstinence', data is missing for patient1."
      },
      "(¬(¬(¬A30 → A31) → A32) → A33)": {
        "formal": "(¬(¬(¬A30 → A31) → A32) → A33)",
        "prover9": "(-(-(-A30 -> A31) -> A32) -> A33)",
        "prover9_expression": "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> pharmacogenetic_response(patient1))",
        "natural": "If it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', then a pharmacogenetic response occurs in patient1."
      },
      "(¬(¬(¬A30 → A31) → A32) → A34)": {
        "formal": "(¬(¬(¬A30 → A31) → A32) → A34)",
        "prover9": "(-(-(-A30 -> A31) -> A32) -> A34)",
        "prover9_expression": "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> metabolizer_status(patient1, poor))",
        "natural": "Provided that it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', patient1 has a poor metabolizer status."
      },
      "(¬(¬(¬A30 → A31) → A32) → ¬A33)": {
        "formal": "(¬(¬(¬A30 → A31) → A32) → ¬A33)",
        "prover9": "(-(-(-A30 -> A31) -> A32) -> -A33)",
        "prover9_expression": "(-(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1)) -> -pharmacogenetic_response(patient1))",
        "natural": "If it is not the case that 'if it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', then a genetic variant is found in patient1', then a pharmacogenetic response does not occur in patient1."
      },
      "(¬(¬A30 → A31) → A32)": {
        "formal": "(¬(¬A30 → A31) → A32)",
        "prover9": "(-(-A30 -> A31) -> A32)",
        "prover9_expression": "(-(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1)) -> genetic_variant_found(patient1, allele1))",
        "natural": "Whenever it is not the case that 'if a biological sample is not collected from patient1, then a biomarker is analyzed', a genetic variant (allele1) is found in patient1."
      },
      "(¬A30 → A31)": {
        "formal": "(¬A30 → A31)",
        "prover9": "(-A30 -> A31)",
        "prover9_expression": "(-biological_sample_collected(patient1, blood) -> biomarker_analyzed(lab1, sample1))",
        "natural": "If a biological sample is not collected from patient1, then lab1 analyzes biomarker sample1."
      },
      "(¬A30 → ¬A31)": {
        "formal": "(¬A30 → ¬A31)",
        "prover9": "(-A30 -> -A31)",
        "prover9_expression": "(-biological_sample_collected(patient1, blood) -> -biomarker_analyzed(lab1, sample1))",
        "natural": "Provided that a biological sample is not collected from patient1, lab1 does not analyze biomarker sample1."
      },
      "(¬A44 → A45)": {
        "formal": "(¬A44 → A45)",
        "prover9": "(-A44 -> A45)",
        "prover9_expression": "(-protocol_amended(trial1, version2) -> recruitment_paused(trial1))",
        "natural": "If the protocol for trial1 is not amended to version2, then recruitment for trial1 is paused."
      },
      "(¬A44 → ¬A45)": {
        "formal": "(¬A44 → ¬A45)",
        "prover9": "(-A44 -> -A45)",
        "prover9_expression": "(-protocol_amended(trial1, version2) -> -recruitment_paused(trial1))",
        "natural": "Under the condition that the protocol for trial1 is not amended to version2, recruitment for trial1 is not paused."
      },
      "(¬G → A7)": {
        "formal": "(¬G → A7)",
        "prover9": "(-G -> A7)",
        "prover9_expression": "(-treatment_effective(trial1) -> shows_abstinence(patient1))",
        "natural": "If the treatment in trial1 is not effective, then patient1 shows abstinence."
      },
      "(¬G → ¬A7)": {
        "formal": "(¬G → ¬A7)",
        "prover9": "(-G -> -A7)",
        "prover9_expression": "(-treatment_effective(trial1) -> -shows_abstinence(patient1))",
        "natural": "Provided that the treatment in trial1 is not effective, patient1 does not show abstinence."
      },
      "A1": {
        "formal": "A1",
        "prover9": "A1",
        "prover9_expression": "participant_completes(patient1, trial1)",
        "natural": "Patient1 completes trial1."
      },
      "A19": {
        "formal": "A19",
        "prover9": "A19",
        "prover9_expression": "irb_approves(ethics_board, trial1)",
        "natural": "The ethics board (IRB) approves trial1."
      },
      "A25": {
        "formal": "A25",
        "prover9": "A25",
        "prover9_expression": "primary_endpoint_met(patient1)",
        "natural": "Patient1 meets the primary endpoint."
      },
      "A27": {
        "formal": "A27",
        "prover9": "A27",
        "prover9_expression": "statistical_significance_reached(trial1, outcome1)",
        "natural": "Statistical significance for outcome1 is reached in trial1."
      },
      "A30": {
        "formal": "A30",
        "prover9": "A30",
        "prover9_expression": "biological_sample_collected(patient1, blood)",
        "natural": "A biological sample (blood) is collected from patient1."
      },
      "A36": {
        "formal": "A36",
        "prover9": "A36",
        "prover9_expression": "ema_reviews(agency_eu, trial1)",
        "natural": "The European agency (EMA) reviews trial1."
      },
      "A4": {
        "formal": "A4",
        "prover9": "A4",
        "prover9_expression": "receives_placebo(patient1)",
        "natural": "Patient1 receives a placebo."
      },
      "A44": {
        "formal": "A44",
        "prover9": "A44",
        "prover9_expression": "protocol_amended(trial1, version2)",
        "natural": "The protocol for trial1 is amended to version2."
      },
      "A5": {
        "formal": "A5",
        "prover9": "A5",
        "prover9_expression": "is_randomized(patient1, groupA)",
        "natural": "Patient1 is randomized into groupA."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "treatment_effective(trial1)",
        "natural": "The treatment in trial1 is effective."
      },
      "¬A14": {
        "formal": "¬A14",
        "prover9": "-A14",
        "prover9_expression": "-data_audited(trial1)",
        "natural": "It is not the case that the data for trial1 is audited."
      },
      "¬A15": {
        "formal": "¬A15",
        "prover9": "-A15",
        "prover9_expression": "-protocol_violation_occurs(trial1)",
        "natural": "A protocol violation does not occur in trial1."
      },
      "¬A32": {
        "formal": "¬A32",
        "prover9": "-A32",
        "prover9_expression": "-genetic_variant_found(patient1, allele1)",
        "natural": "A genetic variant (allele1) is not found in patient1."
      },
      "¬A35": {
        "formal": "¬A35",
        "prover9": "-A35",
        "prover9_expression": "-dose_adjusted(patient1)",
        "natural": "The dose for patient1 is not adjusted."
      },
      "¬A39": {
        "formal": "¬A39",
        "prover9": "-A39",
        "prover9_expression": "-data_missing(patient1)",
        "natural": "Data is not missing for patient1."
      },
      "¬A42": {
        "formal": "¬A42",
        "prover9": "-A42",
        "prover9_expression": "-funding_continued(grant1)",
        "natural": "Grant1 funding is not continued."
      },
      "¬A46": {
        "formal": "¬A46",
        "prover9": "-A46",
        "prover9_expression": "-multicenter_expansion(trial1)",
        "natural": "Trial1 does not undergo a multicenter expansion."
      },
      "¬A49": {
        "formal": "¬A49",
        "prover9": "-A49",
        "prover9_expression": "-replication_study_initiated(trial2)",
        "natural": "Replication study trial2 is not initiated."
      },
      "¬A6": {
        "formal": "¬A6",
        "prover9": "-A6",
        "prover9_expression": "-has_contraindication(patient1, liver_condition)",
        "natural": "Patient1 does not have a contraindication: a liver condition."
      }
    }
  }
}